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Beyond the Glass Ceiling—Achieving Gender Equity in
Risk Stratiﬁcation for Cardiovascular Imaging
Leslee J. Shaw, PHD,* Jagat Narula, MD, PHD†n this issue of iJACC, Coelho-Filho et al. (1) re-
port on the prognostic utility of stress cardiac
magnetic resonance myocardial perfusion imag-
ing (CMR-MPI) for risk stratification of women
and men. Importantly, in this relatively large co-
hort of women and men, there were no gender
differences in the risk of major adverse cardiovas-
cular event (MACE) rates by CMR-MPI results.
For women with ischemia, the annual MACE
rate was 15% as compared to 0.5% for those
with no ischemia. These results are striking given
that now all commonly applied diagnostic imag-
ing modalities can successfully risk stratify both
women and men with equal accuracy including
nuclear, echocardiography, and computed tomo-
graphic angiographic anatomic measurements.
The enormity of this subject must be placed
within the context of the annual burden of car-
diovascular disease that includes nearly 450,000
female deaths annually with nearly 10 million
women living with chronic stable angina (2).
Moreover, this report is compelling, giving the
storied history of diagnostic testing in women
with numerous reports noting technical limita-
tions and a diminished accuracy of testing (3,4).
Numerous factors intensify the dilemma of evalu-
ating women presenting with suspected cardiac
symptoms due to their atypical presentation (i.e.,
less exertional and more stress-related symptoms)
and frequent presentation with nonspecific symp-
toms such as malaise or fatigue. The extent to
which symptom presentation results in a limited
ability to differentiate coronary artery disease (CAD)
From the *Emory University School of Medicine, Atlanta, Georgia; and
the †Zena and Michael A. Wiener Cardiovascular Institute, Mount Sinai
School of Medicine, New York, New York.risk, cardiac imaging modalities are decidedly im-
portant in refining a woman’s risk assessment.
Prior reports have focused on gender differences
in prognostic accuracy for other imaging modali-
ties including large observational reports from
stress echocardiography and stress myocardial per-
fusion SPECT (5–7) and published evidence of
the utility of computed tomographic assessment
of the anatomic burden of obstructive and nonob-
structive CAD (8,9). One could argue as to
which test provides the greatest magnitude of in-
cremental information for refining risk in women,
but in lieu of comparative effectiveness evidence
this would be speculation on the part of the Edi-
tors of this journal. Despite this, the report on
the utility of CMR-MPI in this issue of iJACC
remains an important milestone due to the con-
tinued interest and recent growth in utilization of
this modality. CMR also has several novel mea-
sures that may provide unique value in detecting
risk for female patients, including the documenta-
tion of subendocardial ischemia, microinfarction
with late gadolinium enhancement (LGE), and
the ability with amazing detail to interrogate the
vasculature and composition of plaque in certain
vascular beds. For example, in the recent report
highlighted in this issue (1), the percentage of the
myocardium with LGE was one of the strongest
prognostic variables in women without a history
of prior myocardial infarction.
This report (1) signifies the importance of
gender neutrality in test accuracy for the field
of cardiovascular imaging. Accordingly, the field of
cardiovascular imaging has over the past decade
repeatedly reported on gender differences in prog-
nostic accuracy and importantly prioritized evi-
dence development in women. A focus by the
cardiovascular imaging community on targeted
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925key patient populations, such as women, reflects
that the noninvasive field is oriented toward the
patient by providing the best evidence to guide
accurate and appropriate use of all imaging mo-gender-based pathophysiology of ath-




phy in women com
Impact of diabetesdence plays a strategic role in effecting early
and efficient diagnosis of CAD in females con-
tributing to the reported 40% reduction in car-
diovascular mortality for women in the US overdalities. The development of gender equity evi- the past decade (2).7
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